Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Infect Dis ; 225(6): 1005-1010, 2022 03 15.
Article in English | MEDLINE | ID: mdl-32582947

ABSTRACT

The bacterial pathogen Listeria monocytogenes invades host cells, ruptures the internalization vacuole, and reaches the cytosol for replication. A high-content small interfering RNA (siRNA) microscopy screen allowed us to identify epithelial cell factors involved in L. monocytogenes vacuolar rupture, including the serine/threonine kinase Taok2. Kinase activity inhibition using a specific drug validated a role for Taok2 in favoring L. monocytogenes cytoplasmic access. Furthermore, we showed that Taok2 recruitment to L. monocytogenes vacuoles requires the presence of pore-forming toxin listeriolysin O. Overall, our study identified the first set of host factors modulating L. monocytogenes vacuolar rupture and cytoplasmic access in epithelial cells.


Subject(s)
Listeria monocytogenes , Listeriosis , Bacterial Proteins , Cytoplasm , Cytosol , Hemolysin Proteins , Humans , Listeriosis/microbiology , Vacuoles/microbiology , Vacuoles/physiology
2.
J Neurochem ; 161(6): 492-505, 2022 06.
Article in English | MEDLINE | ID: mdl-34822163

ABSTRACT

COVID-19 is associated with encephalitis in critically ill patients and endothelial dysfunction seems to contribute to this life-threatening complication. Our objective was to determine the hallmark of endothelial activation in COVID-19-related encephalitis. In an observational study in intensive care unit (ICU), we compared vascular biomarkers of critically ill COVID-19 patients with or without encephalitis. To be classified in the encephalitis group, patients had to have new onset of central neurologic symptom, and pathological findings on either brain magnetic resonance imaging (MRI) and/or electroencephalogram (EEG). Among the 32 critically ill COVID-19 consecutive patients, 21 were categorized in the control group and 11 in the encephalitis group. Encephalitis patients had a longer ICU stay than control patients (median length [25th-75th percentile] of 52 [16-79] vs. 20.5 [11-44] days, respectively, p = 0.04). Nine-month overall follow-up mortality reached 21% (7/32 patients), with mortality rates in the encephalitis group and the control group of 27% and 19%, respectively. Encephalitis was associated with significant higher release of soluble endothelial activation markers (sE-selectin, tumor necrosis factor-α (TNF-α), interleukin 6, placental growth factor, and thrombomodulin), but these increases were correlated with TNF-α plasmatic levels. The hypoxia-inducible protein angiopoietin-like 4 (ANGPTL4) was at significantly higher levels in encephalitis patients compared to control patients (p = 0.0099), and in contrary to the other increased factors, was not correlated with TNF-α levels (r = 0.2832, p = 0.1163). Our findings suggest that COVID-19-related encephalitis is a cytokine-associated acute brain dysfunction. ANGPTL4 was the only elevated marker found in encephalitis patients, which was not correlated with systemic inflammation, suggesting that ANGPTL4 might be a relevant factor to predict encephalitis in critically ill COVID-19 patients.


Subject(s)
COVID-19 , Encephalitis , Angiopoietin-Like Protein 4/metabolism , Biomarkers , COVID-19/complications , Critical Illness , Encephalitis/virology , Endothelial Cells , Humans , Intensive Care Units , Tumor Necrosis Factor-alpha
3.
PLoS Pathog ; 17(8): e1009326, 2021 08.
Article in English | MEDLINE | ID: mdl-34339477

ABSTRACT

Metabolic pathways are now considered as intrinsic virulence attributes of pathogenic bacteria and thus represent potential targets for antibacterial strategies. Here we focused on the role of the pentose phosphate pathway (PPP) and its connections with other metabolic pathways in the pathophysiology of Francisella novicida. The involvement of the PPP in the intracellular life cycle of Francisella was first demonstrated by studying PPP inactivating mutants. Indeed, we observed that inactivation of the tktA, rpiA or rpe genes severely impaired intramacrophage multiplication during the first 24 hours. However, time-lapse video microscopy demonstrated that rpiA and rpe mutants were able to resume late intracellular multiplication. To better understand the links between PPP and other metabolic networks in the bacterium, we also performed an extensive proteo-metabolomic analysis of these mutants. We show that the PPP constitutes a major bacterial metabolic hub with multiple connections to glycolysis, the tricarboxylic acid cycle and other pathways, such as fatty acid degradation and sulfur metabolism. Altogether our study highlights how PPP plays a key role in the pathogenesis and growth of Francisella in its intracellular niche.


Subject(s)
Bacterial Proteins/metabolism , Drosophila melanogaster/metabolism , Francisella/pathogenicity , Gram-Negative Bacterial Infections/microbiology , Metabolome , Pentose Phosphate Pathway , Proteome , Animals , Bacterial Proteins/genetics , Drosophila melanogaster/growth & development , Drosophila melanogaster/microbiology , Francisella/metabolism , Gene Expression Regulation, Bacterial , Glycolysis , Macrophages/metabolism , Macrophages/microbiology , Male , Mice , Mice, Inbred C57BL , Mutation
4.
C R Biol ; 344(2): 127-143, 2021 Jul 02.
Article in English | MEDLINE | ID: mdl-34213851

ABSTRACT

Neisseria meningitidis (meningococcus) is a Gram-negative bacterium responsible for two devastating forms of invasive diseases: purpura fulminans and meningitis. Since the first description of the epidemic nature of the illness at the dawn of the nineteenth century, the scientific knowledge of meningococcal infection has increased greatly. Major advances have been made in the management of the disease with the advent of antimicrobial therapy and the implementation of meningococcal vaccines. More recently, an extensive knowledge has been accumulated on meningococcal interaction with its human host, revealing key processes involved in disease progression and new promising therapeutic approaches.


Neisseria meningitidis (méningocoque) est une bactérie à Gram négatif responsable de deux formes gravissimes de maladies invasives : le purpura fulminans et la méningite. Depuis la première description du caractère épidémique de la maladie à l'aube du 19e siècle, les connaissances scientifiques sur les infections méningococciques ont considérablement augmenté. Des progrès majeurs ont été réalisés dans la gestion de la maladie avec l'avènement des agents antimicrobiens et le développement de vaccins contre le méningocoque. De nombreuses connaissances ont récemment été accumulées sur son interaction avec l'être humain, son unique hôte, révélant les processus clés impliqués dans la progression de la maladie et de nouvelles approches thérapeutiques prometteuses.


Subject(s)
Meningococcal Infections , Neisseria meningitidis , Purpura Fulminans , Anti-Bacterial Agents , Humans , Meningococcal Infections/drug therapy , Purpura Fulminans/drug therapy
5.
Cell Microbiol ; 22(4): e13185, 2020 04.
Article in English | MEDLINE | ID: mdl-32185901

ABSTRACT

Neisseria meningitidis (meningococcus) is a Gram-negative bacterium responsible for two devastating forms of invasive diseases: purpura fulminans and meningitis. Interaction with both peripheral and cerebral microvascular endothelial cells is at the heart of meningococcal pathogenesis. During the last two decades, an essential role for meningococcal type IV pili in vascular colonisation and disease progression has been unravelled. This review summarises 20 years of research on meningococcal type IV pilus-dependent virulence mechanisms, up to the identification of promising anti-virulence compounds that target type IV pili.


Subject(s)
Bacterial Adhesion , Fimbriae, Bacterial/classification , Fimbriae, Bacterial/metabolism , Meningococcal Infections/microbiology , Neisseria meningitidis/pathogenicity , Animals , Endothelial Cells/microbiology , Humans , Mice , Virulence
6.
Gut ; 69(9): 1582-1591, 2020 09.
Article in English | MEDLINE | ID: mdl-31822580

ABSTRACT

OBJECTIVE: Helicobacter pylori (Hp) is a major risk factor for gastric cancer (GC). Hp promotes DNA damage and proteasomal degradation of p53, the guardian of genome stability. Hp reduces the expression of the transcription factor USF1 shown to stabilise p53 in response to genotoxic stress. We investigated whether Hp-mediated USF1 deregulation impacts p53-response and consequently genetic instability. We also explored in vivo the role of USF1 in gastric carcinogenesis. DESIGN: Human gastric epithelial cell lines were infected with Hp7.13, exposed or not to a DNA-damaging agent camptothecin (CPT), to mimic a genetic instability context. We quantified the expression of USF1, p53 and their target genes, we determined their subcellular localisation by immunofluorescence and examined USF1/p53 interaction. Usf1-/- and INS-GAS mice were used to strengthen the findings in vivo and patient data examined for clinical relevance. RESULTS: In vivo we revealed the dominant role of USF1 in protecting gastric cells against Hp-induced carcinogenesis and its impact on p53 levels. In vitro, Hp delocalises USF1 into foci close to cell membranes. Hp prevents USF1/p53 nuclear built up and relocates these complexes in the cytoplasm, thereby impairing their transcriptional function. Hp also inhibits CPT-induced USF1/p53 nuclear complexes, exacerbating CPT-dependent DNA damaging effects. CONCLUSION: Our data reveal that the depletion of USF1 and its de-localisation in the vicinity of cell membranes are essential events associated to the genotoxic activity of Hp infection, thus promoting gastric carcinogenesis. These findings are also of clinical relevance, supporting USF1 expression as a potential marker of GC susceptibility.


Subject(s)
Carcinogenesis , Gastric Mucosa , Helicobacter Infections/metabolism , Helicobacter pylori , Stomach Neoplasms , Tumor Suppressor Protein p53/genetics , Upstream Stimulatory Factors/metabolism , Animals , Carcinogenesis/genetics , Carcinogenesis/metabolism , Cell Line , DNA Damage , Gastric Mucosa/metabolism , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Genomic Instability , Helicobacter pylori/metabolism , Helicobacter pylori/pathogenicity , Humans , Mice , Proteasome Endopeptidase Complex/metabolism , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Stomach Neoplasms/microbiology , Ubiquitination
7.
Mol Cell Proteomics ; 18(12): 2418-2432, 2019 12.
Article in English | MEDLINE | ID: mdl-31578219

ABSTRACT

The bacterial pathogen Francisella tularensis possesses a noncanonical type VI secretion system (T6SS) that is required for phagosomal escape in infected macrophages. KCl stimulation has been previously used to trigger assembly and secretion of the T6SS in culture. By differential proteomics, we found here that the amounts of the T6SS proteins remained unchanged upon KCl stimulation, suggesting involvement of post-translational modifications in T6SS assembly. A phosphoproteomic analysis indeed identified a unique phosphorylation site on IglB, a key component of the T6SS sheath. Substitutions of Y139 with alanine or phosphomimetics prevented T6SS formation and abolished phagosomal escape whereas substitution with phenylalanine delayed but did not abolish phagosomal escape in J774-1 macrophages. Altogether our data demonstrated that the Y139 site of IglB plays a critical role in T6SS biogenesis, suggesting that sheath phosphorylation could participate to T6SS dynamics.Data are available via ProteomeXchange with identifier PXD013619; and on MS-Viewer, key lkaqkllxwx.


Subject(s)
Francisella tularensis/metabolism , Type VI Secretion Systems/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cell Line , Electronic Data Processing , Francisella tularensis/genetics , Francisella tularensis/ultrastructure , Gas Chromatography-Mass Spectrometry , Humans , Macrophages/microbiology , Molecular Structure , Mutagenesis, Site-Directed , Phosphorylation , Potassium Chloride/pharmacology , Protein Processing, Post-Translational , Proteomics , Tandem Mass Spectrometry , Type VI Secretion Systems/chemistry , Type VI Secretion Systems/drug effects , Type VI Secretion Systems/genetics
8.
J Infect Dis ; 220(12): 1967-1976, 2019 11 06.
Article in English | MEDLINE | ID: mdl-31420648

ABSTRACT

Staphylococcus aureus is a leading cause of both acute and chronic infections in humans. The importance of the pentose phosphate pathway (PPP) during S. aureus infection is currently largely unexplored. In the current study, we focused on one key PPP enzyme, transketolase (TKT). We showed that inactivation of the unique gene encoding TKT activity in S. aureus USA300 (∆tkt) led to drastic metabolomic changes. Using time-lapse video imaging and mice infection, we observed a major defect of the ∆tkt strain compared with wild-type strain in early intracellular proliferation and in the ability to colonize kidneys. Transcriptional activity of the 2 master regulators sigma B and RpiRc was drastically reduced in the ∆tkt mutant during host cells invasion. The concomitant increased RNAIII transcription suggests that TKT-or a functional PPP-strongly influences the ability of S. aureus to proliferate within host cells by modulating key transcriptional regulators.


Subject(s)
Staphylococcal Infections/microbiology , Staphylococcus aureus/physiology , Stress, Physiological , Transketolase/metabolism , Animals , Carbon/metabolism , Disease Models, Animal , Gene Expression Profiling/methods , Gene Expression Regulation, Bacterial , Gene Silencing , Genes, Bacterial , Humans , Kidney/metabolism , Kidney/microbiology , Metabolomics/methods , Mice , Mutation , Phenotype , Signal Transduction , Staphylococcus aureus/enzymology , Stress, Physiological/genetics , Transketolase/genetics
9.
Nat Commun ; 8(1): 853, 2017 10 11.
Article in English | MEDLINE | ID: mdl-29021545

ABSTRACT

The enzyme fructose-bisphosphate aldolase occupies a central position in glycolysis and gluconeogenesis pathways. Beyond its housekeeping role in metabolism, fructose-bisphosphate aldolase has been involved in additional functions and is considered as a potential target for drug development against pathogenic bacteria. Here, we address the role of fructose-bisphosphate aldolase in the bacterial pathogen Francisella novicida. We demonstrate that fructose-bisphosphate aldolase is important for bacterial multiplication in macrophages in the presence of gluconeogenic substrates. In addition, we unravel a direct role of this metabolic enzyme in transcription regulation of genes katG and rpoA, encoding catalase and an RNA polymerase subunit, respectively. We propose a model in which fructose-bisphosphate aldolase participates in the control of host redox homeostasis and the inflammatory immune response.The enzyme fructose-bisphosphate aldolase (FBA) plays central roles in glycolysis and gluconeogenesis. Here, Ziveri et al. show that FBA of the pathogen Francisella novicida acts, in addition, as a transcriptional regulator and is important for bacterial multiplication in macrophages.


Subject(s)
Francisella tularensis/enzymology , Fructose-Bisphosphate Aldolase/metabolism , Gene Expression Regulation, Bacterial , Animals , Female , Francisella tularensis/genetics , Francisella tularensis/pathogenicity , Fructose-Bisphosphate Aldolase/genetics , Gluconeogenesis , Glucose/metabolism , Macrophages/metabolism , Macrophages/microbiology , Metabolomics , Mice, Inbred BALB C , Oxidative Stress
10.
Article in English | MEDLINE | ID: mdl-28401066

ABSTRACT

Francisella tularensis is a highly infectious Gram-negative bacterium and the causative agent of the zoonotic disease tularemia. This bacterial pathogen can infect a broad variety of animal species and can be transmitted to humans in numerous ways with various clinical outcomes. Although, Francisella possesses the capacity to infect numerous mammalian cell types, the macrophage constitutes the main intracellular niche, used for in vivo bacterial dissemination. To survive and multiply within infected macrophages, Francisella must imperatively escape from the phagosomal compartment. In the cytosol, the bacterium needs to control the host innate immune response and adapt its metabolism to this nutrient-restricted niche. Our laboratory has shown that intracellular Francisella mainly relied on host amino acid as major gluconeogenic substrates and provided evidence that the host metabolism was also modified upon Francisella infection. We will review here our current understanding of how Francisella copes with the available nutrient sources provided by the host cell during the course of infection.


Subject(s)
Adaptation, Physiological , Francisella/metabolism , Francisella/pathogenicity , Host-Pathogen Interactions , Tularemia/metabolism , Adaptation, Physiological/genetics , Amino Acids/metabolism , Animals , Carbohydrate Metabolism , Cytosol/metabolism , Cytosol/microbiology , Francisella/genetics , Glycolysis , Immunity, Innate , Macrophages/metabolism , Macrophages/microbiology , Phagosomes/metabolism , Phagosomes/microbiology , Tularemia/immunology , Tularemia/microbiology , Virulence Factors/metabolism , Zoonoses/microbiology
11.
Mol Microbiol ; 98(3): 518-34, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26192619

ABSTRACT

Intracellular multiplication and dissemination of the infectious bacterial pathogen Francisella tularensis implies the utilization of multiple host-derived nutrients. Here, we demonstrate that gluconeogenesis constitutes an essential metabolic pathway in Francisella pathogenesis. Indeed, inactivation of gene glpX, encoding the unique fructose 1,6-bisphosphatase of Francisella, severely impaired bacterial intracellular multiplication when cells were supplemented by gluconeogenic substrates such as glycerol or pyruvate. The ΔglpX mutant also showed a severe virulence defect in the mouse model, confirming the importance of this pathway during the in vivo life cycle of the pathogen. Isotopic profiling revealed the major role of the Embden-Meyerhof (glycolysis) pathway in glucose catabolism in Francisella and confirmed the importance of glpX in gluconeogenesis. Altogether, the data presented suggest that gluconeogenesis allows Francisella to cope with the limiting glucose availability it encounters during its infectious cycle by relying on host amino acids. Hence, targeting the gluconeogenic pathway might constitute an interesting therapeutic approach against this pathogen.


Subject(s)
Francisella tularensis/metabolism , Animals , Female , Francisella tularensis/genetics , Francisella tularensis/pathogenicity , Genes, Bacterial , Gluconeogenesis , Hep G2 Cells , Humans , Mass Spectrometry , Metabolic Networks and Pathways , Mice , Mice, Inbred BALB C , Tularemia/microbiology , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...